Cat. No.: DIA-0243029
Product Information | |
---|---|
CAS No. | 1965248-01-4 |
Formula | C21H26N4O2S2 |
Molecular Weight | 430.59 |
SMILES | O=S(C1=CC=C(C2=CSC=C2)C=C1)(N3C(N4CCN(C5CCC5)CC4)=NCC3)=O |
Target | Histone Demethylase |
Product Description | KDM2B-IN-2, a potent histone demethylase (kdm2b) inhibitor with an IC50 of 0.021 μM in a KDM2B TR-FRET assay. KDM2B-IN-2 can be used for hyperproliferative diseases research. |
Format & Storage | |
---|---|
Format | Solid |
Color | White to light brown |
Purity | 99.60% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | Powder: -20°C, 3 years; 4°C, 2 years In solvent: -80°C, 6 months; -20°C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.